BioSpace News Archive

Press Releases

Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients

September 30, 2024
·
5 min read
Press Releases

Be Biopharma Announces Preclinical Data for Novel Engineered B Cell Medicine for the Potential Treatment of Hypophosphatasia

September 30, 2024
·
3 min read
Business

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

September 30, 2024
·
3 min read
Press Releases

NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury

September 30, 2024
·
7 min read
Business

PBIRx Announces Key Leadership Addition to Meet Unprecedented Client and Account Team Growth

September 30, 2024
·
3 min read
Drug Development

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

September 30, 2024
·
6 min read
News

89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference

September 30, 2024
·
1 min read
News

Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference

September 30, 2024
·
3 min read
FDA

Johnson & Johnson files for U.S. FDA approval of DARZALEX FASPRO®-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned

September 30, 2024
·
16 min read
Drug Development

Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting

September 30, 2024
·
5 min read